Long-Term Effect [phpr]
Gemfibrosil [lipd, phsu]
Coronary heart disease risk [inpr]
Profile [lbpr]
Patients [podg]
Primary combined hyperlipidaemia [dsyn]
Background [cnce]
Purpose [ftcn]
Present [qnco]
Study [mnob]
To [qlco]
Assess [acty]
Effect [qlco]
Gemfibrosil [lipd, phsu]
Independent [idcn]
Coronary heart disease risk [inpr]
Factor [ftcn]
Patients [podg]
Primary combined hyperlipidaemia [dsyn]
Methods [inpr]
One [qnco]
Five [qnco]
Patients [podg]
Men [popg]
Women [popg]
Aged [orga]
Study [mnob]
Probability [qnco]
Myocardial Infarction [dsyn]
Patients [podg]
Calculated [ftcn]
Using [ftcn]
TEN [dsyn]
Probability [qnco]
Myocardial Infarction [dsyn]
Computer Program [inpr, mnob]
Construct [clas]
Evaluate [ftcn]
Independent [idcn]
Coronary Artery Disease Risk [inpr]
Factor [ftcn]
Patients [podg]
Lipid-lowering diet [topp]
placebo [topp]
month [tmco]
Patients [podg]
Received [qlco]
mg% [qnco]
Gemfibrosil [lipd, phsu]
Daily [tmco]
divided [ftcn]
Two [qnco]
Equal [qlco]
Doses [qnco]
months [tmco]
months [tmco]
Total Cholesterol [lbpr]
High Density Lipoprotein Cholesterol [bacs, lipd]
Triglycerides [bacs, lipd]
Only [qnco]
Low density lipoprotein [aapp, bacs, lipd]
Cholesterol [bacs, strd]
High Density Lipoprotein Cholesterol [bacs, lipd]
Ratio [qnco]
Above [spco]
Systolic blood pressure [clna]
Plasma glucose [lbpr]
Left ventricular mass [fndg]
Index [inpr]
Plasma [bdsu]
Fibrinogen [aapp, bacs, phsu]
Measured [qlco]
Smoking [inbe]
Habits [inbe]
Sex [orgf]
Age [orga]
Physical activity [dora]
Family history [fndg]
coronary heart disease [dsyn]
Evaluated [ftcn]
Mean [qnco]
Probability [qnco]
Myocardial Infarction [dsyn]
Patients [podg]
month [tmco]
This [euka]
High [qlco]
Probability [qnco]
P NOS [aapp, imft]
Age [orga]
Sex [orgf]
Matched Group [grup]
General Population [popg]
Result [ftcn]
Third [qnco]
month [tmco]
treatment [ftcn]
Following [tmco]
Record [inpr]
Total Cholesterol [lbpr]
Cholesterol, LDL [bacs, strd]
Very low density lipoprotein cholesterol [bacs, strd]
High Density Lipoprotein Cholesterol [bacs, lipd]
Triglycerides [bacs, lipd]
Apoprotein [aapp, bacs]
Apoprotein(a) [aapp, bacs]
I- [inch]
Plasma [bdsu]
Fibrinogen [aapp, bacs, phsu]
Estimated [qnco]
Risk [qlco]
Myocardial Infarction [dsyn]
Reduced [qlco]
Delta [inpr]
M NOS [aapp, imft]
Sustained [ftcn]
Twelfth [qnco]
treatment [ftcn]
month [tmco]
Patients [podg]
Withdrawn [fndg]
Study [mnob]
adverse effects [ftcn]
treatment [ftcn]
Conclusion [idcn]
Gemfibrosil [lipd, phsu]
Estimated [qnco]
Risk [qlco]
Myocardial Infarction [dsyn]
Patients [podg]
Primary combined hyperlipidaemia [dsyn]
Level [qlco]
Different [qlco]
One [qnco]
General Population [popg]
This [euka]
Effect [qlco]
Gemfibrosil [lipd, phsu]
Third [qnco]
month [tmco]
Evidence [ftcn]
Time [tmco]
Attribute [idcn]
reduction [npop]
Triglyceride [bacs, lipd]
fibrinogen levels [lbpr]
Increase [ftcn]
High Density Lipoprotein Cholesterol [bacs, lipd]
Concentrations [menp]
Moderate [qlco]
Decrease [qlco]
Total Cholesterol [lbpr]
Cholesterol, LDL [bacs, strd]
Level [qlco]
